Homocysteine vs cholesterol: Competing views, or a unifying explanation of arteriosclerotic cardiovascular disease?

Laboratory Medicine

Volumn 29, Issue 7, 1998, Pages 410-417

  Cramer, David A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLESTEROL; CYANOCOBALAMIN; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; METHIONINE; PYRIDOXINE;

AMINO ACID METABOLISM; CORONARY ARTERY ATHEROSCLEROSIS; DIET; ENZYME IMMUNOASSAY; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; LABORATORY TEST; REVIEW; SCREENING TEST; STROKE; VITAMIN INTAKE;

EID: 0031874264     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1093/labmed/29.7.410     Document Type: Review

References (19)

1. 6, and cardiovascular disease. JAMA. 1998;279:392-393.
2. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111-128.
3. McCully KS. Homocysteine and vascular disease. Clinical Chemistry Check Sample, CC-94-5. Chicago, Ill: ASCP; 1994;34:65-77.
4. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiol as active intermediates. J Pharmacol Exp Ther. 1981;218:739-749.
5. Selhub J, Jacques PF, Wilson PWF, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
6. Wu KS, Chook P, Lolin YI, et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 1997;96:2542-2544.
7. Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91:6369-6373.
8. Harker LA, Slichter SJ, Scott CR, et al. Homocystinuria: vascular injury and arterial thrombosis. New Engl J Med. 1974;291:537-543.
9. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
10. Nygård O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230-236.
11. Alfthan G, Aro A, Gey KF. Plasma homocysteine and cardiovascular disease mortality. Lancet. 1997;349:397.
12. Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med. 1998;158:862-867.
13. Boushey CJ, Berestord, SSA, Omenn GS, et al. A meta-analysis of plasma homocysteine as a risk factor for arteriosclerosis vascular disease and the potential preventive role of folic acid. In: International Congress on Homocysteine Metabolism: From Basic Science to Clinical Medicine. Norwall, Mass: Kluwer Academic, 1995.
14. Evans RW, Shaten BJ, Hempel JD, et al. Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial. Arterioscler Thromb Vasc Biol. 1997;17:1947-1953.
15. McCully KS. Chemical pathology of homocysteine: I. Atherogenesis. Ann Clin Lab Sci. 1993;23:477-493.
16. Naruszewica M, Mirkiewicz E, Olszewski AJ, et al. Thiolation of low-density lipoprotein causes increased aggregation and interaction with cultured macrophages. Nutr Metab Cardiovasc Dis. In press.
17. Peterson JC, Spence JD. Vitamins and progression of atherosclereosis in hyper-homocyt(e)inaemia. Lancet. 1998;351:263.
18. Rimm EB, Willett WC, Hu FB, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 1998;279:359-364.
19. Macko RF. B-vitamins lower homocysteine levels in the blood; may reduce vessel damage in stroke patients. Press release at 23rd International Joint Conference on Stroke and Cerebral Circulation; February 1998; Orlando, Fla,